Shan Lu

5.4k citations
209 papers · 3.5k · 2 hit papers · h-index 28

Impact in

Papers in

Shan Lu

196 papers receiving 3.5k citations

Shan Lu's Hit Papers

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma 2022 · 366 citations
3660+1+3Years since publication100200300

Peers

Shan Lu
Comparison fields: 5 of 137
  • Microbiology 63
  • Hepatology 227
  • Parasitology 190
  • Infectious Diseases 437
  • Endocrinology 124
Replace Michael S. Bronze with:
Michael S. Bronze United States
Aftab Ahmed United States
Harold Tjalsma Netherlands
Richard P. MacDermott United States
Sharon Amit Israel
Chee‐Kiat Tan Singapore
Bing Li China
Yechezkel Sidi Israel
Masahiko Makino Japan
Aikichi Iwamoto Japan
Shan Lu relative to Michael S. Bronze United States Michael S. Bronze's profile →
Citations per field
00.5×4.8×
Michael S. Bronze · 1×
Citations per year

Countries citing papers authored by Shan Lu

Since Specialization
Citations

This map shows the geographic impact of Shan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lu more than expected).

Fields of papers citing papers by Shan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lu. The network helps show where Shan Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Shan Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shan Lu Line = papers co-authored together Shan Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 209 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Hit paper breakdown →
2022366
2
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
Hit paper breakdown →
2021227
3 2018169
4 2020146
5 1993119
6 2016102
7 201587
8 202078
9 202063
10 201362
11 201460
12 200756
13 201855
14 202349
15 201539
16 201936
17 201136
18 201935
19 201335
20 202134

About Shan Lu

Shan Lu is a scholar working on Molecular Biology, Infectious Diseases, Pulmonary and Respiratory Medicine, Immunology and Plant Science, having authored 209 papers that have together received 3.5k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (47 papers), Gut microbiota and health (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Actinomycetales infections and treatment (8 papers), Microbial Natural Products and Biosynthesis (8 papers), Microbial Metabolism and Applications (7 papers), Viral gastroenteritis research and epidemiology (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Microbiology (63 citations), Hepatology (227 citations), Parasitology (190 citations), Infectious Diseases (437 citations) and Endocrinology (124 citations). Shan Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianguo Xu, H. J. Yang, Dong Jin, Yulei Wang, Yinghui Guan, Xiaoyi Dai, Ji Pu, R. J. Roman, David L. Mattson and Allen W. Cowley. Their work appears in journals such as INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, Frontiers in Microbiology, Journal of Ethnopharmacology, Medicine and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact